In-vivo | Tissuepathology.com

Virscio Deploys Proscia Software To Improve Efficiency Of Drug Research And Development

Erica Goodpaster — Tue, 25 Apr 2023 11:21:40 +0000

Proscia: Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies NEW HAVEN, CONN. and PHILADELPHIA – April 24, 2023 – Proscia®, a leading provider of digital and computational pathology solutions, today announced that Virscio, a leading provider of translational research and development services, has deployed Concentriq® for Research. The contract research organization (CRO) is […]

The post Virscio Deploys Proscia Software To Improve Efficiency Of Drug Research And Development first appeared on Tissuepathology.com.

In Vivo: Pharma’s Digital Pathology Build-Out; Part 1 – The State Of Play

Erica Goodpaster — Mon, 05 Dec 2022 14:15:32 +0000

In Vivo Pharma Intelligence, has published an article discussing where pharmaceutical companies are finding value as they use digital pathology throughout their research and development functions. Executive Summary Pharma companies are applying digital pathology throughout their research and development functions. Where are they now finding value? To read the rest of the article, visit In […]

The post In Vivo: Pharma’s Digital Pathology Build-Out; Part 1 – The State Of Play first appeared on Tissuepathology.com.

Regulator OKs DeepBio’s AI-based Prostate Cancer Pathology Diagnosis SW

Erica Goodpaster — Mon, 15 Nov 2021 12:13:27 +0000

DeepBio said its DeepDx-Prostate Pro, an artificial intelligence (AI)-based pathology diagnosis assistance software, has received a Class 3 in-vitro diagnostic medical device from the Ministry of Food and Drug Safety. According to the company, the approval marks the first AI-based medical device that assists in classifying prostate cancer severity in the world. The company had […]

The post Regulator OKs DeepBio’s AI-based Prostate Cancer Pathology Diagnosis SW first appeared on Tissuepathology.com.

Indica Labs Announces New Masterclass Webinar

Erica Goodpaster — Thu, 21 Oct 2021 12:22:11 +0000

Indica Labs Webinar Announcement 2021 Masterclass: Deep Dive into AI-Based Nuclear Segmentation and Phenotyping Part II 04 November 2021 8:00 PDT | 11:00 EDT | 16:00 GMT Register Now Learning Objectives Learn how HALO AI can advance your image analysis with an easy-to-use interface Learn about available HALO AI networks and options and how to use […]

The post Indica Labs Announces New Masterclass Webinar first appeared on Tissuepathology.com.

2nd Olympus Discovery Summit Connects Microscopists to Advance Research and Imaging

Erica Goodpaster — Wed, 13 Oct 2021 13:00:43 +0000

WALTHAM, Mass., (October 11, 2021)— The second Olympus Discovery Summit—a free two-day event—will take place on October 26–27, 2021. Centered on the theme Advance Your Imaging, microscopists can connect with their peers during two full days of virtual presentations to discuss how they are using imaging techniques to advance their research. Using Microscopy Imaging to […]

The post 2nd Olympus Discovery Summit Connects Microscopists to Advance Research and Imaging first appeared on Tissuepathology.com.

Aiforia enters the clinic with CE-IVD marked product and €2.2M EU grant

Dr. Keith J. Kaplan — Thu, 05 Dec 2019 17:47:40 +0000

Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.2 million in funding from the EU’s Horizon 2020 program. The EU grant was awarded to support Aiforia’s ongoing development work of its artificial intelligence (AI) solutions for digital pathology with the goal of bringing […]

The post Aiforia enters the clinic with CE-IVD marked product and €2.2M EU grant first appeared on Tissuepathology.com.